[Gynecomastia associated with the simultaneous use of cisapride and lansoprazole].
Cuervo Martín
J R
JR
García Ortega
P
P
Sánchez Sánchez
A
A
Carvajal García-Pando
A
A
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000368:Aged; D000897:Anti-Ulcer Agents / Q000009:adverse effects*; D020117:Cisapride / Q000009:adverse effects*; D004338:Drug Combinations; D005765:Gastrointestinal Agents / Q000009:adverse effects*; D006177:Gynecomastia / Q000139:chemically induced*; D006801:Humans; D064747:Lansoprazole; D008297:Male; D009853:Omeprazole / Q000009:adverse effects* / Q000031:analogs & derivatives
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000897:Anti-Ulcer Agents; D004338:Drug Combinations; D005765:Gastrointestinal Agents; D064747:Lansoprazole; D009853:Omeprazole; D020117:Cisapride